MONACO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 14.181
EU - Europa 12.752
AS - Asia 8.967
SA - Sud America 1.126
AF - Africa 190
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 8
Totale 37.275
Nazione #
US - Stati Uniti d'America 13.968
RU - Federazione Russa 4.643
SG - Singapore 3.462
CN - Cina 3.021
GB - Regno Unito 2.785
IT - Italia 1.337
BR - Brasile 906
SE - Svezia 903
VN - Vietnam 720
HK - Hong Kong 711
FR - Francia 684
DE - Germania 624
IE - Irlanda 583
FI - Finlandia 559
KR - Corea 300
UA - Ucraina 175
IN - India 136
CA - Canada 125
TR - Turchia 93
JP - Giappone 83
AR - Argentina 82
BE - Belgio 81
ID - Indonesia 73
PL - Polonia 64
BD - Bangladesh 61
NL - Olanda 56
MX - Messico 52
NG - Nigeria 50
IQ - Iraq 48
ES - Italia 46
AU - Australia 45
AT - Austria 40
ZA - Sudafrica 40
EC - Ecuador 32
IR - Iran 30
VE - Venezuela 27
PK - Pakistan 25
UZ - Uzbekistan 24
SA - Arabia Saudita 23
CL - Cile 21
CO - Colombia 20
JO - Giordania 18
LT - Lituania 18
EG - Egitto 17
CH - Svizzera 16
IL - Israele 16
MA - Marocco 15
PH - Filippine 15
PY - Paraguay 14
TN - Tunisia 14
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
GR - Grecia 13
NO - Norvegia 13
HU - Ungheria 11
RO - Romania 11
DO - Repubblica Dominicana 10
LB - Libano 10
LV - Lettonia 10
NP - Nepal 10
BO - Bolivia 9
DZ - Algeria 9
HR - Croazia 9
AL - Albania 8
DK - Danimarca 8
KZ - Kazakistan 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
OM - Oman 7
PE - Perù 7
TG - Togo 7
UY - Uruguay 7
CR - Costa Rica 6
KE - Kenya 6
KG - Kirghizistan 6
TW - Taiwan 6
JM - Giamaica 5
KH - Cambogia 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
LI - Liechtenstein 4
LU - Lussemburgo 4
MY - Malesia 4
PS - Palestinian Territory 4
PT - Portogallo 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BJ - Benin 3
BY - Bielorussia 3
CG - Congo 3
CI - Costa d'Avorio 3
EU - Europa 3
ML - Mali 3
Totale 37.227
Città #
Southend 2.318
Singapore 1.815
Ashburn 1.636
Chandler 1.605
Moscow 1.584
San Jose 1.136
Dallas 1.129
Jacksonville 1.128
Woodbridge 831
Ann Arbor 710
Hong Kong 700
Verona 603
Dublin 575
Beijing 529
Houston 495
The Dalles 418
New York 321
Los Angeles 261
Wilmington 248
Lawrence 232
Princeton 232
Jinan 224
Ho Chi Minh City 213
Nanjing 205
Helsinki 167
Buffalo 152
Hebei 152
Shenyang 145
Hanoi 137
Munich 119
Tianjin 113
Columbus 97
Council Bluffs 90
São Paulo 90
Milan 88
Ningbo 87
Redondo Beach 87
Santa Clara 86
Sindelfingen 86
Zhengzhou 81
Brussels 80
Changsha 79
Nanchang 77
Lancaster 76
Tokyo 74
Boardman 72
Haikou 72
Redmond 70
Turku 70
Dearborn 64
Guangzhou 64
Montreal 62
Taizhou 59
Hangzhou 58
Seoul 58
Orem 57
Seattle 55
Dong Ket 54
Washington 54
Warsaw 53
Jakarta 51
Redwood City 51
Chicago 50
Jiaxing 49
London 48
Rome 46
Falls Church 45
Taiyuan 44
Abuja 43
Denver 41
Istanbul 40
Norwalk 39
Stockholm 39
Fairfield 38
Fuzhou 38
Chennai 37
Brooklyn 35
Frankfurt am Main 35
San Francisco 33
Haiphong 32
Rio de Janeiro 32
Toronto 32
Bologna 30
Da Nang 30
Boston 29
Lanzhou 28
Nuremberg 27
Atlanta 24
Belo Horizonte 24
Lappeenranta 24
Paris 24
Amsterdam 23
Johannesburg 23
Adelaide 22
Falkenstein 22
Phoenix 22
Vienna 22
Clearwater 21
Tashkent 21
Auburn Hills 20
Totale 23.567
Nome #
Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker Disease with the P102L mutation. 268
Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage. 263
Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy 262
La biopsia del nervo periferico. Indicazioni, metodiche e principali quadri patologici [Peripheral nerve biopsy. Indications, methods and principal pathological pictures] 261
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 252
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 251
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 250
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 243
Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples 242
Accuracy of diagnostic criteria for sporadic Creutzfeldt-Jakob disease among rapidly progressive dementia. 237
Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin 235
AUMENTATA ESPRESSIONE DEL GENE COX-2 NEL SANGUE PERIFERICO DI PAZIENTI CON ICTUS ISCHEMICO 233
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 232
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 231
AZT-induced mitochondrial myopathy 224
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 224
A 49-year-old man with neuropsychiatric symptoms followed by progressive cognitive decline. 218
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 218
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 218
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 217
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 216
[Hypertrophic neuropathies beginning in infancy: a study of 3 cases (author's transl)] 211
A test for Creutzfeldt-Jakob disease using nasal brushings. 210
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 209
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 209
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 208
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 208
A case of acute fulminant multiple sclerosis treated with alemtuzumab 208
Molecular analysis of iatrogenic scrapie in Italy 206
Brentuximab vedotin: axonal microtubule's Apollyon 205
Time for a Consensus Conference on pain in neurorehabilitation 205
Cytoskeletal changes in cultured human fibroblasts following exposure to 2,5-hexanedione 204
Cognitive onset in multiple sclerosis 204
Lesione bilaterale della corteccia cingolata anteriore: studio polisonnografico ad autonomico di un caso. 203
Risk factors for post-polio syndrome among an Italian population: a case-control study. 203
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 203
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 203
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 203
Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis. 202
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 202
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 201
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 201
Unusual case of solitary intraparenchymal brain plasmacytoma. 200
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 200
Binding of monoclonal anti-myelin-associated glycoprotein antibodies to human foetal peripheral neurons in culture 199
Adult-onset migraine-related ophthalmoplegia and omolateral fetal-type posterior cerebral artery. 199
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 199
Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping 197
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 197
Immunoaffinity reactors for prion protein qualitative analysis 194
Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease 194
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 194
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 194
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy 194
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 193
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 191
High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD 191
The proteome: anno Domini 2002 190
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 187
Association of prolonged QTc interval with Takotsubo cardiomyopathy: A neurocardiac syndrome inside the mystery of the insula of Reil 187
Convergent pathological and ultrasound features in hereditary syndromic and non‐syndromic minifascicular neuropathy related to DHH 187
The dispersion of myocardial repolarization in ischemic stroke and intracranial hemorrhage 185
Neurodegeneration-associated proteins in human olfactory neurons collected by nasal brushing 185
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 184
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 184
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 184
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. 183
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 183
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 183
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 183
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 182
Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease 182
Cerebral amyloidoses: molecular pathways and therapeutic challenges 179
Spectral analysis of cardiovascular responses in POTS 179
QTc Prolongation in Patients with Dementia and Mild Cognitive Impairment: Neuropsychological and Brain Imaging Correlations 177
Epilepsy in multiple sclerosis: The role of temporal lobe damage 177
Specific and surrogate cerebrospinal fluid markers in Creutzfeldt–Jakob Disease (chapter 17) 175
Nervous system: subclinical target of SARS-CoV-2 infection 175
Response to Nagai et al. 174
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 174
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 173
Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes 172
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease 171
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. 171
Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia 169
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 169
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 169
T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy 168
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 168
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 168
Friedreich's ataxia. A light- and electron microscopic study of peripheral nerve biopsies 167
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 167
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 167
Inherited neuroaxonal dystrophy in C6 deficient rabbits 166
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 166
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 166
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 165
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 165
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 165
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies 164
Totale 19.774
Categoria #
all - tutte 121.151
article - articoli 114.085
book - libri 0
conference - conferenze 2.778
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.288
Totale 242.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 0 0 0 0 43 271 124
2021/20222.251 193 765 20 275 50 110 32 111 65 67 149 414
2022/20234.226 306 483 379 745 384 971 35 307 432 22 103 59
2023/20242.063 80 163 179 215 272 467 78 120 19 129 218 123
2024/20255.162 277 357 226 840 259 195 240 259 802 301 430 976
2025/202614.603 1.085 871 1.134 2.333 3.892 1.052 1.363 808 1.216 849 0 0
Totale 37.580